LabGenius announces research collaboration with Ablynx

By The Science Advisory Board staff writers

July 16, 2021 -- LabGenius has announced a research collaboration with Ablynx, a Sanofi company, for therapeutic proteins.

The company develops machine learning for protein engineering via its machine learning-driven evolution engine (EVA platform) and will combine its expertise with Ablynx's existing therapeutic Nanobody protein technology, it said. The optimized candidates will then be advanced by Ablynx into further validation studies.

Financial terms of the partnership were not disclosed.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.